Retrospective comparative survival analysis of ablation plus systemic therapy versus systemic therapy alone for breast cancer liver metastases, stratified by extrahepatic metastases status

Background: Current decision-making for the treatment of breast cancer liver metastases (BCLM) using ablation lacks strong evidence, especially for patients combined with extrahepatic metastases. Purpose: To assess whether ablation plus systemic therapy (AS) improves survival outcomes in patients wi...

Full description

Saved in:
Bibliographic Details
Main Authors: Xuxiazi Zou, Hong-Liang Zou, Xuan Luo, Xu-Wei Chen, Wei-Ling Huang, Chao Zhang, Ge Ren, Jin-Hua Huang, Xue Han, Yi-Quan Jiang
Format: Article
Language:English
Published: Elsevier 2025-02-01
Series:Breast
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S0960977625000050
Tags: Add Tag
No Tags, Be the first to tag this record!